Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-25 @ 3:30 AM
NCT ID:
NCT06798805
Eligibility Criteria:
Inclusion criteria for patients:
* age ≥ 18 years.
* patients with WHO2017-defined diagnosis of Myeloproliferative Neoplasms.
* patients at first diagnosis.
* Informed consent signed.
Exclusion criteria for patients:
\- patients with concomitant second neoplasia
Inclusion criteria for Healthy Donors:
* age ≥ 18 years.
* Informed consent signed.
Exclusion criteria for Healthy Donors:
\- Healthy Donors with neoplasia.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06798805
Study Brief:
Protocol Section:
NCT06798805